Real questions, real gaps
What reps got wrong, and then got right.
10 real questions from pharma programs on Atrivity, each answered by between 80 and 1,390 field and pharmacy staff. On average, the error rate fell from 66% at the first attempt to 32% at the last.
Product and science160 learners
Atheroma plaque formation is directly related to...
first attempt76%last attempt20%
What the company gainsReps who can hold a scientific conversation with cardiologists and earn credibility for the product story
Selling skills80 learners
What happens if I open a pharmacy visit by asking the pharmacist "Do you have time?"
first attempt79%last attempt36%
What the company gainsBetter visit openings and more productive calls per day
Compliance1,390 learners
Can I pay a supplier to service a doctor's Doppler ultrasound machine?
first attempt74%last attempt35%
What the company gainsFewer transfers of value that breach the industry code, and less exposure to sanctions and reputational damage
Selling skills160 learners
How should you rebut a false objection about one of our products?
first attempt78%last attempt40%
What the company gainsObjections answered with data instead of argument, so fewer lost prescriptions
Product and science390 learners
How should our OTC mucolytic effervescent tablets be taken?
first attempt58%last attempt28%
What the company gainsPharmacy staff give correct usage advice, which improves outcomes and repeat purchase
Compliance1,390 learners
We sponsor an Italian doctor who practises in a Madrid hospital to attend a congress in Rome. Is this a cross-border activity?
first attempt55%last attempt26%
What the company gainsCorrect disclosure and approval of HCP sponsorships, with no transparency-report errors
Compliance389 learners
Any communication or written document...
first attempt60%last attempt32%
What the company gainsLower antitrust risk from careless emails and notes in the field
Product and science425 learners
In the METAVIR scoring system for liver damage...
first attempt64%last attempt37%
What the company gainsReps can follow how hepatologists stage patients and position treatment at the right moment
Product and science396 learners
What are the main dosing differences between our oncology drug and its main competitor?
first attempt62%last attempt37%
What the company gainsA clear, compliant differentiation message on adherence and patient convenience
Product and science221 learners
In the pivotal phase 3 trial of our osteoporosis biologic vs placebo, what was the relative risk reduction in new vertebral fractures?
first attempt56%last attempt32%
What the company gainsReps quote the key efficacy figure accurately, which keeps promotion on-label and convincing
Real questions from client programs, anonymised and translated. Correct answers not shown; metrics unchanged.